Journal Article

Emtricitabine for adults with lamivudine-resistant chronic hepatitis B virus infection

Cochrane Database of Systematic Reviews (2017) 2017(1)
DOI: 10.1002/14651858.CD012496
0Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the benefits and harms of emtricitabine versus no intervention, placebo, and non-emtricitabine interventions in adults with lamivudine-resistant, chronic hepatitis B virus infection.

Cite

CITATION STYLE

APA

Mok, S., Mohan, S., Hunter, K. M., Wang, Y. R., & Judge, T. A. (2017). Emtricitabine for adults with lamivudine-resistant chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews, 2017(1). https://doi.org/10.1002/14651858.CD012496

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free